130 related articles for article (PubMed ID: 10484047)
21. Correlates of total homocysteine plasma concentration in type 2 diabetes.
Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
[TBL] [Abstract][Full Text] [Related]
22. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
23. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
24. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
25. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Emoto M; Kanda H; Shoji T; Kawagishi T; Komatsu M; Mori K; Tahara H; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Diabetes Care; 2001 Mar; 24(3):533-8. PubMed ID: 11289481
[TBL] [Abstract][Full Text] [Related]
26. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
Okumura K; Aso Y
Metabolism; 2003 Nov; 52(11):1517-22. PubMed ID: 14624417
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia.
Flicker L; Vasikaran SD; Thomas J; Acres JM; Norman P; Jamrozik K; Hankey GJ; Almeida OP
Stroke; 2006 Feb; 37(2):547-9. PubMed ID: 16373648
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians.
Refsum H; Yajnik CS; Gadkari M; Schneede J; Vollset SE; Orning L; Guttormsen AB; Joglekar A; Sayyad MG; Ulvik A; Ueland PM
Am J Clin Nutr; 2001 Aug; 74(2):233-41. PubMed ID: 11470726
[TBL] [Abstract][Full Text] [Related]
29. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
30. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
[TBL] [Abstract][Full Text] [Related]
31. Increasing homocysteine levels and diabetic autonomic neuropathy.
Cohen JA; Jeffers BW; Stabler S; Schrier RW; Estascio R
Auton Neurosci; 2001 Mar; 87(2-3):268-73. PubMed ID: 11476288
[TBL] [Abstract][Full Text] [Related]
32. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
[TBL] [Abstract][Full Text] [Related]
33. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered?
Bondevik GT; Schneede J; Refsum H; Lie RT; Ulstein M; Kvåle G
Eur J Clin Nutr; 2001 Oct; 55(10):856-64. PubMed ID: 11593347
[TBL] [Abstract][Full Text] [Related]
34. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
[TBL] [Abstract][Full Text] [Related]
35. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
[TBL] [Abstract][Full Text] [Related]
36. Evidence of altered homocysteine metabolism in chronic renal failure.
Henning BF; Riezler R; Tepel M; Langer K; Raidt H; Graefe U; Zidek W
Nephron; 1999; 83(4):314-22. PubMed ID: 10575293
[TBL] [Abstract][Full Text] [Related]
37. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes.
Davies L; Wilmshurst EG; McElduff A; Gunton J; Clifton-Bligh P; Fulcher GR
Diabetes Care; 2001 Oct; 24(10):1805-9. PubMed ID: 11574446
[TBL] [Abstract][Full Text] [Related]
38. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population.
Nilsson K; Gustafson L; Hultberg B
Clin Chem; 2000 May; 46(5):691-6. PubMed ID: 10794752
[TBL] [Abstract][Full Text] [Related]
39. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
Stehouwer CD; Gall MA; Hougaard P; Jakobs C; Parving HH
Kidney Int; 1999 Jan; 55(1):308-14. PubMed ID: 9893141
[TBL] [Abstract][Full Text] [Related]
40. Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years.
Monsen AL; Refsum H; Markestad T; Ueland PM
Clin Chem; 2003 Dec; 49(12):2067-75. PubMed ID: 14633879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]